TGF-beta Receptor-activated P38 MAP Kinase Mediates Smad-independent TGF-beta Responses

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2002 Jul 12

PMID 12110587

Citations 294

Authors

Li Yu

Mindy C Hebert

Ying E Zhang

Affiliations

Soon will be listed here.

Abstract

Through the action of its membrane-bound type I receptors, transforming growth factor-beta (TGF-beta) elicits a wide range of cellular responses that regulate cell proliferation, differentiation and apoptosis. Many of the signaling responses induced by TGF-beta are mediated by Smad proteins, but certain evidence has suggested that TGF-beta can also signal independently of Smads. We found in mouse mammary epithelial (NMuMG) cells, which respond to TGF-beta treatment in multiple ways, that TGF-beta-induced activation of p38 MAP kinase is required for TGF-beta-induced apoptosis, epithelial-to-mesenchymal transition (EMT), but not growth arrest. We further demonstrated that activation of p38 is independent of Smads using a mutant type I receptor, which is incapable of activating Smads but still retains the kinase activity. This mutant receptor is sufficient to activate p38 and cause NMuMG cells to undergo apoptosis. However, it is not sufficient to induce EMT. These results indicate that TGF-beta receptor signals through multiple intracellular pathways and provide first-hand biochemical evidence for the existence of Smad-independent TGF-beta receptor signaling.

Citing Articles

Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers.

Sravani A, Thomas J Heliyon. 2025; 11(3):e41964.

PMID: 39959483 PMC: 11830326. DOI: 10.1016/j.heliyon.2025.e41964.

Inhibition of the Transforming Growth Factor-β Signaling Pathway Confers Neuroprotective Effects on Beta-Amyloid-Induced Direct Neurotoxicity and Microglia-Mediated Neuroinflammation.

Tiong S, Mohgan R, Quek J, Liew J, Wong G, Thang Z Neurol Res Int. 2025; 2025:8948290.

PMID: 39949498 PMC: 11824711. DOI: 10.1155/nri/8948290.

Non-small cell lung cancer map and analysis: exploring interconnected oncogenic signal integrators.

Gottumukkala S, Palanisamy A Mamm Genome. 2025; .

PMID: 39939487 DOI: 10.1007/s00335-025-10110-6.

Broadening horizons: molecular mechanisms and disease implications of endothelial-to-mesenchymal transition.

Qian C, Dong G, Yang C, Zheng W, Zhong C, Shen Q Cell Commun Signal. 2025; 23(1):16.

PMID: 39789529 PMC: 11720945. DOI: 10.1186/s12964-025-02028-y.

5-Methoxytryptophan Protects against Toll-Like Receptor 2-Mediated Renal Tissue Inflammation and Fibrosis in a Murine Unilateral Ureteral Obstruction Model.

Wu J, Lee G, Chueh Y, Kuo C, Hsu Y, Wu K J Innate Immun. 2025; 17(1):78-94.

PMID: 39773569 PMC: 11801855. DOI: 10.1159/000543275.

References

Wrana J . Regulation of Smad activity. Cell. 2000; 100(2):189-92. DOI: 10.1016/s0092-8674(00)81556-1. View

Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E . TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 1996; 10(19):2462-77. DOI: 10.1101/gad.10.19.2462. View

Ono K, Han J . The p38 signal transduction pathway: activation and function. Cell Signal. 2000; 12(1):1-13. DOI: 10.1016/s0898-6568(99)00071-6. View

Kusanagi K, Inoue H, Ishidou Y, Mishima H, Kawabata M, Miyazono K . Characterization of a bone morphogenetic protein-responsive Smad-binding element. Mol Biol Cell. 2000; 11(2):555-65. PMC: 14793. DOI: 10.1091/mbc.11.2.555. View

Choy L, Skillington J, Derynck R . Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J Cell Biol. 2000; 149(3):667-82. PMC: 2174852. DOI: 10.1083/jcb.149.3.667. View

Landstrom M, Heldin N, Bu S, Hermansson A, Itoh S, Ten Dijke P . Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells. Curr Biol. 2000; 10(9):535-8. DOI: 10.1016/s0960-9822(00)00470-x. View

Faure S, Lee M, Keller T, Ten Dijke P, Whitman M . Endogenous patterns of TGFbeta superfamily signaling during early Xenopus development. Development. 2000; 127(13):2917-31. DOI: 10.1242/dev.127.13.2917. View

McEwen D, Peifer M . Wnt signaling: Moving in a new direction. Curr Biol. 2000; 10(15):R562-4. DOI: 10.1016/s0960-9822(00)00611-4. View

Pardali K, Kurisaki A, Moren A, Ten Dijke P, Kardassis D, Moustakas A . Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J Biol Chem. 2000; 275(38):29244-56. DOI: 10.1074/jbc.M909467199. View

10.

Lehmann K, Janda E, Pierreux C, Rytomaa M, Schulze A, McMahon M . Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 2000; 14(20):2610-22. PMC: 316988. DOI: 10.1101/gad.181700. View

11.

Jordan J, Landau E, Iyengar R . Signaling networks: the origins of cellular multitasking. Cell. 2000; 103(2):193-200. PMC: 3619409. DOI: 10.1016/s0092-8674(00)00112-4. View

12.

Davis R . Signal transduction by the JNK group of MAP kinases. Cell. 2000; 103(2):239-52. DOI: 10.1016/s0092-8674(00)00116-1. View

13.

Chen X, Rubock M, Whitman M . A transcriptional partner for MAD proteins in TGF-beta signalling. Nature. 1996; 383(6602):691-6. DOI: 10.1038/383691a0. View

14.

Hayashi H, Abdollah S, Qiu Y, Cai J, Xu Y, Grinnell B . The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell. 1997; 89(7):1165-73. DOI: 10.1016/s0092-8674(00)80303-7. View

15.

Feng X, Derynck R . A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity. EMBO J. 1997; 16(13):3912-23. PMC: 1170015. DOI: 10.1093/emboj/16.13.3912. View

16.

Fanger G, Johnson N, Johnson G . MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. EMBO J. 1997; 16(16):4961-72. PMC: 1170131. DOI: 10.1093/emboj/16.16.4961. View

17.

Nakao A, Afrakhte M, Moren A, Nakayama T, Christian J, Heuchel R . Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 1997; 389(6651):631-5. DOI: 10.1038/39369. View

18.

Zawel L, Dai J, Buckhaults P, Zhou S, Kinzler K, Vogelstein B . Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell. 1998; 1(4):611-7. DOI: 10.1016/s1097-2765(00)80061-1. View

19.

Chen Y, Hata A, Lo R, Wotton D, Shi Y, Pavletich N . Determinants of specificity in TGF-beta signal transduction. Genes Dev. 1998; 12(14):2144-52. PMC: 317013. DOI: 10.1101/gad.12.14.2144. View

20.

Whitman M . Smads and early developmental signaling by the TGFbeta superfamily. Genes Dev. 1998; 12(16):2445-62. DOI: 10.1101/gad.12.16.2445. View